Results     22-May-24
Announcements
Strides Pharma Science reports consolidated net profit of Rs 18.18 crore in the March 2024 quarter
Sales rise 9.90% to Rs 1084.04 crore
Net profit of Strides Pharma Science reported to Rs 18.18 crore in the quarter ended March 2024 as against net loss of Rs 9.54 crore during the previous quarter ended March 2023. Sales rose 9.90% to Rs 1084.04 crore in the quarter ended March 2024 as against Rs 986.37 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 70.61 crore in the year ended March 2024 as against net loss of Rs 202.64 crore during the previous year ended March 2023. Sales rose 9.83% to Rs 4051.12 crore in the year ended March 2024 as against Rs 3688.39 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1084.04986.37 10 4051.123688.39 10
OPM %16.7111.65 -14.013.93 -
PBDT87.4561.56 42 292.79-25.92 LP
PBT37.690.63 5883 72.11-269.17 LP
NP18.18-9.54 LP -70.61-202.64 65

Previous News
  Board of Strides Pharma Science recommends final dividend
 ( Corporate News - 22-May-24   15:41 )
  Strides Pharma hits 52-week high on reporting turnaround Q4 performance
 ( Hot Pursuit - 22-May-24   15:14 )
  Strides Pharma Science reports consolidated net profit of Rs 18.18 crore in the March 2024 quarter
 ( Results - Announcements 22-May-24   14:24 )
  Strides Pharma Global receives USFDA approval for Sucralfate Oral Suspension
 ( Corporate News - 22-May-24   10:07 )
  Strides Pharma Science to convene board meeting
 ( Corporate News - 14-May-24   14:28 )
  Strides Pharma rises afte receiving US FDA nod for hyperphosphatemia treatment drug
 ( Hot Pursuit - 10-May-24   13:03 )
  Strides Pharma Global receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg
 ( Corporate News - 10-May-24   12:50 )
  Strides Pharma Science allots 10,000 equity shares under ESOP
 ( Corporate News - 29-Apr-24   13:23 )
  Strides Pharma Global receives USFDA approval for Fluoxetine Tabs
 ( Corporate News - 09-Apr-24   09:54 )
  Strides Pharma gets US FDA nod for antidepressant drug
 ( Hot Pursuit - 09-Apr-24   09:14 )
  Strides Pharma’s Chennai facility gets 2 observations
 ( Hot Pursuit - 08-Apr-24   09:47 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top